Trial Profile
Safety and efficacy of dolutegravir based therapy in adolescent patients with HIV-1 infection: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections
- 29 Dec 2016 New trial record
- 20 Dec 2016 Results published in the Journal of Antimicrobial Chemotherapy